BRAF mutation status in gastrointestinal stromal tumors. - Wikidata - awgldk - TriplyDB

BRAF mutation status in gastrointestinal stromal tumors.

BRAF mutation status in gastrointestinal stromal tumors.

http://www.wikidata.org/entity/Q54702771

about

Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors Human variation databases Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications.PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.Targeted therapy for cancer: the gastrointestinal stromal tumor model.Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches.Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).Gastrointestinal stromal tumor - an evolving concept.Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation.No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.Recent advances and novel agents for gastrointestinal stromal tumor (GIST)A rare giant gastrointestinal stromal tumor of the stomach traversing the upper abdomen: a case report and literature review Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor: Evaluation of a Pooled Case Series.Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.Drug repurposing for gastrointestinal stromal tumor.BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance.MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors Surgical resection should be taken into consideration for the treatment of small gastric gastrointestinal stromal tumors.Gastrointestinal stromal tumours--an update for histopathologists.Special considerations in pediatric gastrointestinal tumors.Targeted therapy in rare cancers--adopting the orphans.Management of gastrointestinal stromal tumors.Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).Hairy cell leukemia-new genes, new targets.GISTogram: a graphic presentation of the growing GIST complexity.Gastrointestinal stromal tumours: from KIT to succinate dehydrogenase.Gastrointestinal stromal tumors: what do we know now?Treatments for gastrointestinal stromal tumors that are resistant to standard therapies.Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.MicroRNAs and Gastrointestinal Stromal Tumor.

P2860

Q28602517-67666B50-B3B7-44C6-8108-67020DAC0E4F Q28750141-342019F6-46DB-47EE-9318-13DDE49689A0 Q30245586-A2091B07-B84B-4C32-82F4-40E2D7200F0C Q33688428-19BBAB00-DDB0-447E-9E89-3D74932C7FB3 Q33776119-4C22F922-4C8B-49D7-A9A4-285DF61A5FE3 Q33802730-48C4D89F-C9B9-4734-83D9-A6621113905E Q33807742-950F46FB-6CDE-4833-89C9-BF02ED400023 Q34171517-C921B918-6EF4-4D74-A7F0-CF2F25371C2F Q34274467-F2F45E66-4846-4336-AA94-72658B89EC81 Q34928165-01AC8647-694C-42F6-A0CD-4EF74CB0F6D7 Q35108718-05A14159-E629-48FD-97A5-FD9FA1BC8FE2 Q35350491-342C647D-833C-4462-B6C0-CB906DAC81FD Q35625368-B39015B3-47E8-4B05-9BA3-819F4903FD62 Q36025994-ACE8292F-F91B-40EE-A830-394703829E47 Q36059870-1781F423-0A4F-4043-9BB5-49E2D2D838CD Q36118178-EAAA9BB7-B33B-41DD-8B40-64164964B6D7 Q36369656-DF238D65-8194-4ACD-8E94-458976881184 Q36478117-9CAD7B25-4F41-4B12-8887-138F6C105287 Q36561734-EDBEA8B0-0840-494C-B43F-80BE32FE30C0 Q36587153-CA112FCE-8ECF-4C98-84E7-CF0A721AF0B1 Q36850606-264B41DE-5E78-41B0-8B54-772F60315F9A Q37001194-3210FA56-ED8B-43A3-AE7A-C4BADC9157D5 Q37016582-D92906C5-1C06-4A13-9949-80A2B29B859D Q37182248-1C138D33-8EAF-4712-A35C-DA038E2D4A1D Q37327430-9937666F-31C0-406D-A352-71B2A17463A2 Q37365970-8656D9F3-924E-47AB-80A3-05D3BE5C8795 Q37888736-9CA32178-ED7D-49B7-B2A9-6FC60483E073 Q37954210-8EFA7DEB-48A4-487E-AE62-914B7443C72C Q38042324-625CA73E-63CD-4827-B78B-617510FE0E5F Q38081983-6FF17F64-741B-4A24-A82F-33BB68B2D39A Q38090985-94D7BCD8-BCCE-4A19-B96F-8D055B9C24CD Q38112821-B2528C28-210B-4307-8C34-136B7448B8C0 Q38119931-80A20BAC-D15C-4712-98F5-DC367AF6161E Q38124726-C4F89D71-AC86-4D08-8D5B-0048486AA0E0 Q38131403-04E65060-080D-48EA-8341-F4CDF216A4A6 Q38151827-9FD3F97E-5F5E-4EB7-A7C3-976043BE4708 Q38175310-10D84327-5CF4-4AB2-97B4-D50E6B277105 Q38268165-9DC8C673-728D-43CE-80DC-32793A1F01A2 Q38399838-1D881D14-0BBB-4DD0-91B9-3B407D5ECDA3 Q38667013-E6A86AC5-46DE-4A5B-8B55-C0515C675751

P2860

BRAF mutation status in gastrointestinal stromal tumors.

http://www.wikidata.org/entity/Q54702771

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

BRAF mutation status in gastrointestinal stromal tumors.

@en

BRAF mutation status in gastrointestinal stromal tumors.

@nl

type

label

BRAF mutation status in gastrointestinal stromal tumors.

@en

BRAF mutation status in gastrointestinal stromal tumors.

@nl

prefLabel

BRAF mutation status in gastrointestinal stromal tumors.

@en

BRAF mutation status in gastrointestinal stromal tumors.

@nl

P1433

Q54702771-B0C4132E-89EA-4273-A5FD-3F59DA2EF43F

P1476

Q54702771-8D67CC88-70B6-4FCB-A219-4D29A711405B

P2093

Q54702771-2829BCB5-A3F1-42CD-B9F4-7DFCBFBF0F4B

Q54702771-3622B5FE-EE2F-4CA9-991F-8585CE06C631

Q54702771-4D5FDF94-129D-4702-994F-1647AE8D4F63

Q54702771-5242ADF8-C2B0-4387-9E53-23C48AAA7CBB

Q54702771-5CD4D79F-E33E-490E-A915-55A12322BE11

Q54702771-B42F371F-35DB-4561-BE34-9D0788128B4D

Q54702771-BECD3BCD-10B6-4861-A2D7-93BA2632474D

Q54702771-EF7549DE-D2D3-4096-83D4-1AD137B3AF0A

Q54702771-FB08C141-C81D-44EA-9CA3-12CF6F9CCCE2

P2860

Q54702771-119D8A86-4D02-4737-B149-D4D6346849E9

Q54702771-20BD7B49-9416-49F7-945A-8E59608CDDDB

Q54702771-22ED9136-8D07-42FE-AD25-758AA42C6706

Q54702771-29CA4DE0-848D-48C2-BAA4-59FD38EB2590

Q54702771-517F47E9-C6B4-453A-A178-3FA4845ACBD7

Q54702771-5C5C4CFC-67CC-4884-953E-D308840B6015

Q54702771-7B650533-BC31-4807-8C48-6C0DDB517472

Q54702771-80293FBB-6A2A-4020-950A-3484892F5692

Q54702771-951780AB-0D10-4230-B603-678BBD7BC888

Q54702771-B375F4DC-F1E8-40B7-B6EC-E82789D5F48A

P304

Q54702771-1B40EAEC-E5E4-479A-ACFA-BEFF32F958F6

P31

Q54702771-BA72FD4D-F0C7-49EC-910F-722661132B30

P356

Q54702771-2A733484-B33F-4097-BE3D-A964012FAC6C

P407

Q54702771-D07AB007-67B2-4E87-ADE1-7537688CB8D6

P433

Q54702771-235B5EBE-66C7-4D67-8302-7D90D1C1A770

P478

Q54702771-DEF00011-EA2C-44A3-BF1A-A3EA3B296A14

P577

Q54702771-41D49A8C-EC00-4C93-AA4C-BD9AEF91CE7B

P5875

Q54702771-95BDBA22-15AA-400A-8A85-B2ADF0D54F21

P698

Q54702771-E762B2AE-3411-4AE3-9812-50D9AEE7DE6D

P356

AJCPPCKGA2QGBJ1R

P1433

American Journal of Clinical Pathology

P1476

BRAF mutation status in gastrointestinal stromal tumors.

@en

P2093

Charlotte Primois

http://www.w3.org/2001/XMLSchema#string

Frédérique Boury

http://www.w3.org/2001/XMLSchema#string

Isabelle Hostein

http://www.w3.org/2001/XMLSchema#string

Jean-François Emile

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Coindre

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Scoazec

http://www.w3.org/2001/XMLSchema#string

Jérome Denard

http://www.w3.org/2001/XMLSchema#string

Nicolas Faur

http://www.w3.org/2001/XMLSchema#string

Pierre-Paul Bringuier

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

Mutations of the BRAF gene in human cancer

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

Rapid screening of 4000 individuals for germ-line variations in the BRAF gene.

Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.

PDGFRA activating mutations in gastrointestinal stromal tumors.

Somatic activation of KIT in distinct subtypes of melanoma.

Raf kinases: oncogenesis and drug discovery.

P304

141-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1309/AJCPPCKGA2QGBJ1R

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40730770

http://www.w3.org/2001/XMLSchema#string

P698

20023270

http://www.w3.org/2001/XMLSchema#string